DRF-1042, CAS [[200619-13-2]]

Produktübersicht

• Artikelname: DRF-1042, CAS [[200619-13-2]]
• Artikelnummer: MCE-HY-125331
• Hersteller Artikelnummer: HY-125331
• Alternativnummer: MCE-HY-125331-100MG,MCE-HY-125331-10MMX1ML,MCE-HY-125331-50MG,MCE-HY-125331-5MG,MCE-HY-125331-10MG,MCE-HY-125331-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

DRF-1042 is an orally active derivative of Camptothecin. DRF-1042 acts to inhibit DNA topoisomerase I. DRF-1042 shows good anticancer activity against a panel of human cancer cell lines including multi-agent resistance (MDR) phenotype[1][2].

Produkteigenschaften

• Molekulargewicht: 408.40
• Reinheit: 98.06
• CAS Nummer: [200619-13-2]
• Formel: C22H20N2O6
• Target-Kategorie: ADC Payload,Topoisomerase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: ADC Related